OnKure Therapeutics, Inc. Class A Common Stock
Symbol: OKUR (NASDAQ)
2.77
▲ (3.78%) 0.101
Company Description:
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Key Stats
- Today's Open: $2.68
- Today's High: $2.79
- Today's Low: $2.62
- Today's Volume: 26.76K
- Yesterday Close: $2.67
- Yesterday High: $2.8
- Yesterday Low: $2.67
- Yesterday Volume: 67.15K
- Last Min Volume: 200
- Last Min High: $2.79
- Last Min Low: $2.79
- Last Min VWAP: $2.79
Company Profile
- Name: OnKure Therapeutics, Inc. Class A Common Stock
- Website: https://www.onkuretherapeutics.com
- Listed Date: 2024-10-07
- Location: BOULDER, CO
- Market Status: Active
- CIK Number: 0001637715
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $36.12M
- Round Lot: 100
- Outstanding Shares: 13.53M
- Asset Type: CS
RECENT FILINGS FOR OKUR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-24 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 424B3 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-26 | 8-K | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |